Block on Trump's Asylum Ban Upheld by Supreme Court
Standing issue in patent infringement suit
Abraxis Bioscience, Inc. v. Navinta LLC., 09-1539, concerned a plaintiff's suit for infringement of its patents related to methods of using low concentrations of ropivacaine hydrochloride to treat pain. In vacating the district court's finding that defendant's Abbreviated New Drug Application (ANDA) product would directly infringe and contribute and induce infringement of certain claims of plaintiff's patents, the court remanded the matter in concluding that the district court erred in failing to dismiss plaintiff's action for lack of standing because, without the transfer of legal title of the patents, plaintiff had no standing to bring this infringement action.
Meeting with a lawyer can help you understand your options and how to best protect your rights. Visit our attorney directory to find a lawyer near you who can help.
Sign into your Legal Forms and Services account to manage your estate planning documents.Sign In
Create an account allows to take advantage of these benefits: